Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma

被引：0
|
作者：
Hayasaka, K. [1 ]
Shiono, S. [2 ]
Matsumura, Y. [3 ]
Suzuki, H. [3 ]
Yanagawa, N. [4 ]
Abe, J. [5 ]
Sagawa, M. [6 ]
Sakurada, A. [7 ]
Katahira, M. [7 ]
Takahashi, S. [5 ]
Endoh, M. [1 ]
Okada, Y. [7 ]
机构：
[1] Yamagata Prefectural Cent Hosp, Dept Thorac Surg, Yamagata, Japan
[2] Yamagata Prefectural Cent Hosp, Thorac Surg, Yamagata, Japan
[3] Fukushima Med Univ, Fukushima, Japan
[4] Yamagata Prefectural Cent Hosp, Pathol, Yamagata, Japan
[5] Miyagi Canc Ctr, Thorac Surg, Natori, Miyagi, Japan
[6] Tohoku Med & Pharmaceut Univ, Dept Endoscopy, Sendai, Miyagi, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Thorac Surg, Sendai, Miyagi, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Surgery; Prognosis; un-common EGFR mutation;
D O I：
10.1016/j.jtho.2018.08.1910
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.16-03
引用
下载
收藏
页码：S1004 / S1004
页数：1
相关论文
共 50 条
  • [31] Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma
    Renaud, Stephane
    Seitlinger, Joseph
    Guerrera, Francesco
    Reeb, Jeremie
    Beau-Faller, Michele
    Voegeli, Anne-Claire
    Siat, Joelle
    Clement-Duchene, Christelle
    Tiotiu, Angelica
    Santelmo, Nicola
    Costardi, Lorena
    Ruffini, Enrico
    Falcoz, Pierre-Emmanuel
    Vignaud, Jean-Michel
    Massard, Gilbert
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) : 1069 - 1078
  • [32] Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma
    Stéphane Renaud
    Joseph Seitlinger
    Francesco Guerrera
    Jérémie Reeb
    Michèle Beau-Faller
    Anne-Claire Voegeli
    Joelle Siat
    Christelle Clément-Duchêne
    Angelica Tiotiu
    Nicola Santelmo
    Lorena Costardi
    Enrico Ruffini
    Pierre-Emmanuel Falcoz
    Jean-Michel Vignaud
    Gilbert Massard
    Annals of Surgical Oncology, 2018, 25 : 1069 - 1078
  • [33] The Impact of EGFR Mutations on the Prognosis of Patients with Resected Stage I Lung Adenocarcinoma
    Kitamura, Jiro
    Tapias, Luis
    Mathisen, Douglas
    Lanuti, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S620 - S621
  • [34] EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis
    Villena-Vargas, J.
    Mynard, N.
    Voza, F.
    Nasar, A.
    Chow, O.
    Lee, B.
    Harrison, S.
    Stiles, B.
    Port, J.
    Altorki, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S443 - S444
  • [35] Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
    Brindel, Aurelien
    Althakfi, Wajd
    Barritault, Marc
    Watkin, Emmanuel
    Maury, Jean-Michel
    Bringuier, Pierre-Paul
    Girard, Nicolas
    Brevet, Marie
    JOURNAL OF THORACIC DISEASE, 2020, 12 (09) : 4643 - +
  • [36] Prognostic Effect of EGFR Gene Mutation for Recurrence in Completely Resected Lung Adenocarcinoma
    Park, I. K.
    Hyun, K.
    Park, S.
    Kang, C. H.
    Kim, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2348 - S2348
  • [37] Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
    Zhang, Huan
    Shan, Guangyao
    Cai, Benjie
    Bi, Guoshu
    Chen, Zhencong
    Liang, Jiaqi
    Besskaya, Valeria
    Zheng, Yuansheng
    Guo, Weigang
    Wang, Lin
    Xu, Songtao
    Zhan, Cheng
    THORACIC CANCER, 2021, 12 (22) : 3011 - 3018
  • [38] Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma
    Marco Dal Molin
    Amanda L. Blackford
    Abdulrehman Siddiqui
    Aaron Brant
    Christy Cho
    Neda Rezaee
    Jun Yu
    Jin He
    Matthew Weiss
    Ralph H. Hruban
    Christopher Wolfgang
    Michael Goggins
    Annals of Surgical Oncology, 2017, 24 : 2379 - 2386
  • [39] Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma
    Dal Molin, Marco
    Blackford, Amanda L.
    Siddiqui, Abdulrehman
    Brant, Aaron
    Cho, Christy
    Rezaee, Neda
    Yu, Jun
    He, Jin
    Weiss, Matthew
    Hruban, Ralph H.
    Wolfgang, Christopher
    Goggins, Michael
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (08) : 2379 - 2386
  • [40] Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas
    Makoto Sonobe
    Masashi Kobayashi
    Masashi Ishikawa
    Ryutaro Kikuchi
    Ei Nakayama
    Tsuyoshi Takahashi
    Toshi Menju
    Kazumasa Takenaka
    Ryo Miyahara
    Cheng-Long Huang
    Kenichi Okubo
    Toru Bando
    Hiroshi Date
    Annals of Surgical Oncology, 2012, 19 : 347 - 354
12345